Correlation Between Inhibikase Therapeutics and Cardio Diagnostics
Can any of the company-specific risk be diversified away by investing in both Inhibikase Therapeutics and Cardio Diagnostics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Inhibikase Therapeutics and Cardio Diagnostics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Inhibikase Therapeutics and Cardio Diagnostics Holdings, you can compare the effects of market volatilities on Inhibikase Therapeutics and Cardio Diagnostics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Inhibikase Therapeutics with a short position of Cardio Diagnostics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Inhibikase Therapeutics and Cardio Diagnostics.
Diversification Opportunities for Inhibikase Therapeutics and Cardio Diagnostics
0.25 | Correlation Coefficient |
Modest diversification
The 3 months correlation between Inhibikase and Cardio is 0.25. Overlapping area represents the amount of risk that can be diversified away by holding Inhibikase Therapeutics and Cardio Diagnostics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cardio Diagnostics and Inhibikase Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Inhibikase Therapeutics are associated (or correlated) with Cardio Diagnostics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cardio Diagnostics has no effect on the direction of Inhibikase Therapeutics i.e., Inhibikase Therapeutics and Cardio Diagnostics go up and down completely randomly.
Pair Corralation between Inhibikase Therapeutics and Cardio Diagnostics
Considering the 90-day investment horizon Inhibikase Therapeutics is expected to generate 1.06 times less return on investment than Cardio Diagnostics. But when comparing it to its historical volatility, Inhibikase Therapeutics is 1.49 times less risky than Cardio Diagnostics. It trades about 0.11 of its potential returns per unit of risk. Cardio Diagnostics Holdings is currently generating about 0.08 of returns per unit of risk over similar time horizon. If you would invest 28.00 in Cardio Diagnostics Holdings on September 3, 2024 and sell it today you would earn a total of 2.00 from holding Cardio Diagnostics Holdings or generate 7.14% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Inhibikase Therapeutics vs. Cardio Diagnostics Holdings
Performance |
| Timeline |
| Inhibikase Therapeutics |
| Cardio Diagnostics |
Inhibikase Therapeutics and Cardio Diagnostics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Inhibikase Therapeutics and Cardio Diagnostics
The main advantage of trading using opposite Inhibikase Therapeutics and Cardio Diagnostics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Inhibikase Therapeutics position performs unexpectedly, Cardio Diagnostics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cardio Diagnostics will offset losses from the drop in Cardio Diagnostics' long position.| Inhibikase Therapeutics vs. DiaMedica Therapeutics | Inhibikase Therapeutics vs. Milestone Pharmaceuticals | Inhibikase Therapeutics vs. Seres Therapeutics | Inhibikase Therapeutics vs. Oncolytics Biotech |
| Cardio Diagnostics vs. Immix Biopharma | Cardio Diagnostics vs. Cns Pharmaceuticals | Cardio Diagnostics vs. Sonnet Biotherapeutics Holdings | Cardio Diagnostics vs. Zura Bio Limited |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Cryptocurrency Center module to build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency.
Other Complementary Tools
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |